Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-FR
Language English French
Date Updated 2022-09-10 2022-03-03
Drug Identification Number 02399334 02399334
Brand name CALCITRIOL INJECTION USP CALCITRIOL INJECTION USP
Common or Proper name CALCITRIOL INJECTION USP CALCITRIOL INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients CALCITRIOL CALCITRIOL
Strength(s) 1MCG 1MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 25 AMPOULES 25 AMPOULES
ATC code A11CC A11CC
ATC description VIT A AND D, INCL COMBINATIONS OF THE TWO VIT A AND D, INCL COMBINATIONS OF THE TWO
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2022-03-01 2022-03-01
Estimated end date 2022-09-16 2022-07-15
Actual end date 2022-09-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product will be available at McKesson by end of next week. Demand increase and delay in manufacturing timelines. Product is on 50% preventative allocation to ensure a fair share distribution and to limit supply interruption.
Health Canada comments